| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |